SGLT-2 - Globe Thesis - Globe Thesis

Keyword [SGLT-2] Result: 21 - 40 \| Page: 2 of 3
21.	Study On Biological Activity And Clinical Application Of SGLT-2 Inhibitors
22.	A Network Meta-analysis Of SGLT-2 Inhibitors,GLP-1receptor Agonists And DPP-4 Inhibitors For Improving NAFLD
23.	The Invention Study Of SGLT-2 Inhibitors On Hemodynamics And Endothelial Function In Type 2 Diabetes
24.	Meta-analysis Of The Long-term Safety Of Empagliflozin In The Treatment Of Type 2 Diabetes Melitus
25.	Dapagliflozin Improves The Dysfunction Of Human Umbilical Vein Endothelial Cells By Inhibiting SGLT-2 To Down-regulate Autophagy Induced By High Glucose/high Fat
26.	The Dtudy Of SGLT-2 Inhibitor In Patients With Type 2 Diabetes Cardiovascular Risk Factors In Clinical Application
27.	Effects Of SGLT-2 Inhibitors On Cardiac Function And Prognosis In Chronic Heart Failure:A Meta-analysis Of Randomized Controlled Trials
28.	Effects Of SGLT-2 Inhibitor Combined With Angiotensin Receptor Antagonist On Early Renal Function In Patients With Type 2 Diabetes Mellitus Complicated And Hypertension
29.	The Safety And Efficacy Of SGLT-2 Inhibitors In Chronic Heart Failure:A Meta-Analysis
30.	The Effect Of SGLT-2 Inhibitor Empagliflozin On Ischemic Brain And Related Mechanism Study In Mice
31.	Effects Of SGLT-2 Inhibitors On The Prognosis Of Patients With Heart Failure With Reduced Ejection Fraction:
32.	Dapagliflozin Alleviates Hepatic Steatosis By Restoring Autophagy Via The AMPK-mTOR Pathway
33.	A Meta-analysis Of Cardiac Function And Survival Prognosis Of Heart Failure With SGLT-2 Inhibitors
34.	Effect Of SGLT-2 Inhibitors On Insulin Resistance And RAAS System In Patients With Primary Aldosteronism
35.	Effect Of SGLT-2 Inhibitor On Renal Function And Metabolic Indexes In Patients With Diabetic Kidney Disease Combined With Metabolic Syndrome In Sichuan
36.	Effect Of Probiotics On Blood Glucose Control And Intestinal Function In Patients With Type 2 Diabetes Mellitus
37.	Effects Of SGLT-2 Inhibitors On Body Compositions In Type 2 Diabetes Mellitus:Meta-analysis
38.	Meta-analysis Of SGLT-2 Inhibitor In The Treatment Of Heart Failure With Preserved Ejection Fraction In Patients With Type 2 Diabetes Mellitus
39.	Clinical Efficacy And Safety Study Of SGLT-2 Inhibitor Dapagliflozin To Improve Cognitive Dysfunction In Combination With Type 2 Diabetes
40.	Efficacy Of SGLT-2 Inhibitors In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: A Meta-Analysis
<<First <Prev Next> Last>> Jump to